NCRNA00171 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.383000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.077600E-01
Normal-vs-Stage2
4.167000E-01
Normal-vs-Stage3
3.234200E-01
Normal-vs-Stage4
3.583400E-01
Stage1-vs-Stage2
1.687150E-01
Stage1-vs-Stage3
7.504100E-02
Stage1-vs-Stage4
4.212200E-01
Stage2-vs-Stage3
1.510430E-01
Stage2-vs-Stage4
5.381200E-01
Stage3-vs-Stage4
1.523350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.471600E-01
Normal-vs-AfricanAmerican
3.869800E-01
Normal-vs-Asian
3.704000E-01
Caucasian-vs-AfricanAmerican
8.599900E-02
Caucasian-vs-Asian
1.652580E-01
AfricanAmerican-vs-Asian
7.625600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.319400E-01
Normal-vs-Female
4.478600E-01
Male-vs-Female
5.913400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.801800E-01
Normal-vs-Age(41-60Yrs)
4.479200E-01
Normal-vs-Age(61-80Yrs)
4.290800E-01
Normal-vs-Age(81-100Yrs)
4.428000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.256350E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.760100E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.488560E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.649400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.117000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.377800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.262800E-01
Normal-vs-Daily Drinker
3.819600E-01
Normal-vs-Weekly Drinker
4.055800E-01
Normal-vs-Occasional Drinker
4.821800E-01
Normal-vs-Social Drinker
4.717400E-01
Non Drinker-vs-Daily Drinker
3.020000E-01
Non Drinker-vs-Weekly Drinker
6.315200E-01
Non Drinker-vs-Occasional Drinker
4.647200E-01
Non Drinker-vs-Social Drinker
4.012800E-01
Daily Drinker-vs-Weekly Drinker
6.669200E-01
Daily Drinker-vs-Occasional Drinker
1.771840E-01
Daily Drinker-vs-Social Drinker
1.571980E-01
Weekly Drinker-vs-Occasional Drinker
3.305400E-01
Weekly Drinker-vs-Social Drinker
3.009400E-01
Occasional Drinker-vs-Social Drinker
9.236200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.495000E-01
Normal-vs-Grade 2
7.537700E-02
Normal-vs-Grade 3
9.806000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.663550E-01
Grade 1-vs-Grade 3
1.005570E-01
Grade 1-vs-Grade 4
2.495000E-01
Grade 2-vs-Grade 3
4.664600E-01
Grade 2-vs-Grade 4
7.537700E-02
Grade 3-vs-Grade 4
9.806000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.507800E-01
Normal-vs-NonDiabetic
4.207000E-01
Diabetic-vs-NonDiabetic
4.160000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.522800E-01
Normal-vs-NoPancreatitis
4.348200E-01
Pancreatitis-vs-NoPancreatitis
1.054500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.894400E-01
Normal-vs-N1
4.092200E-01
N0-vs-N1
3.040500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.670600E-01
Normal-vs-TP53-NonMutant
5.274400E-01
TP53-Mutant-vs-TP53-NonMutant
1.579090E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
